Clinical Trial

Study of the Role of the Induced Membrane in the Reconstruction of Bone Loss in the Limbs

Study acronym: MEMBRAN
Recruiting
View on ClinicalTrials.gov →
Summary
Masquelet's induced membrane technique is a two-stage reconstructive surgery for severe bone fractures commonly used by military orthopedists. The particularity of this technique relies on the synthesis of a biological membrane induced by the transient implantation of a surgical cement (= 1st stage surgery). The presence of the induced membrane in the reconstruction space defines a microenvironment or "biological chamber" favourable to osteogenesis, positively influencing the repair of the lesion after implantation of an autologous bone graft (= 2nd stage of surgery). In view of the excellent clinical results obtained with this procedure, the Masquelet technique has gradually become a reference treatment in the field of orthopedic and trauma surgery. However, orthopedic surgeons sometimes observe failures in bone consolidation. To our knowledge, the role played by induced membrane in these therapeutic failures has never been studied.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2021-05-11; most recent amendment 2022-12-20.
Status change: Not Yet Recruiting → Recruiting 2021-12-10
Trial Details
NCT Number NCT04883502
Lead Sponsor Direction Centrale du Service de Santé des Armées
Conditions Bone Loss
Enrollment 80 participants
Start Date 2021-10-29
Primary Completion 2028-04 (estimated)
Study Completion 2028-04 (estimated)
Updated on ClinicalTrials.gov 2022-12-21